Evidence mapPaperPMID 41705339Full record

ArticleHypertension (Dallas, Tex. : 1979)2026

Angiotensin-(1-7) Activates Proopiomelanocortin Neurons in the Arcuate Nucleus.

Victoria L Vernail, Darren L Mehay, Katherine D Kimbark, Jordan A Tanner, Sarah S Bingaman, Yuval Silberman, Amy C Arnold

Abstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Victoria L VernailDepartment of Neuroscience and Experimental Therapeutics, Pennsylvania State University College of Medicine, Hershey.ORCID 0000-0002-4910-9280
Darren L MehayDepartment of Neuroscience and Experimental Therapeutics, Pennsylvania State University College of Medicine, Hershey.ORCID 0000-0003-0058-3296
Katherine D KimbarkDepartment of Neuroscience and Experimental Therapeutics, Pennsylvania State University College of Medicine, Hershey.ORCID 0009-0001-1126-7240
Jordan A TannerDepartment of Neuroscience and Experimental Therapeutics, Pennsylvania State University College of Medicine, Hershey.
Sarah S BingamanDepartment of Neuroscience and Experimental Therapeutics, Pennsylvania State University College of Medicine, Hershey.
Yuval SilbermanDepartment of Neuroscience and Experimental Therapeutics, Pennsylvania State University College of Medicine, Hershey.ORCID 0000-0002-4694-4053
Amy C ArnoldDepartment of Neuroscience and Experimental Therapeutics, Pennsylvania State University College of Medicine, Hershey.ORCID 0000-0002-1380-6017

Funding

Angiotensin-(1-7) and Cardiovascular Derangements in Obesity HypertensionR01HL170140 · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · 2025 to 2025
$720k
Angiotensin-(1-7) and Hypothalamic control of blood pressureR01HL156986 · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · 2025 to 2025
$450k
Angiotensin-(1-7) engages hypothalamic arcuate-paraventricular nucleus inhibitory pathways to lower blood pressureF31HL170693 · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · 2025 to 2025
$9k
NHLBI NIH HHS F31 HL170693NHLBI NIH HHS R01 HL156986NHLBI NIH HHS R01 HL170140
6 · The paper itself

Abstract

backgroundAngiotensin-(1-7) lowers blood pressure and improves metabolic outcomes in animal models of obesity and hypertension. Whether central mechanisms are involved in these protective cardiometabolic effects is poorly understood. In this study, we hypothesized that angiotensin-(1-7) engages central neurocircuits originating in the arcuate nucleus of the hypothalamus under normal conditions and in diet-induced obesity.

methodsMale mice were placed on a control diet or 60% high-fat diet for 12 weeks. Immunohistochemistry, in situ hybridization, electrophysiology, and physiological approaches were employed to determine whether angiotensin-(1-7) activates arcuate neurocircuits, to characterize the molecular identity of activated arcuate cells, and to assess the functional importance of this neurocircuit in blood pressure regulation.

resultsUnder control diet conditions, systemic angiotensin-(1-7) administration (2 mg/kg, SC) increased the number of c-fos positive cells in the arcuate nucleus. Angiotensin-(1-7)

conclusionsThese findings suggest that angiotensin-(1-7) activates arcuate proopiomelanocortin neurons and engages arcuate-paraventricular inhibitory neurocircuits to lower blood pressure under normal conditions. In obesity, this circuit appears disrupted, which could contribute to the elevated blood pressure in this model.

Indexed as

Angiotensin IArcuate Nucleus of HypothalamusHypertensionNeuronsObesityPeptide FragmentsPro-OpiomelanocortinAnimalsBlood PressureDiet, High-FatDisease Models, AnimalImmunohistochemistryMaleMiceMice, Inbred C57BLAngiotensin Iangiotensin I (1-7)Peptide FragmentsPro-Opiomelanocortinangiotensinblood pressureimmunohistochemistryneuronsobesity

Identifiers

PMID41705339
PMCPMC12997222

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.